Stay updated on OPTIM Study: Immunotherapy in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.

Latest updates to the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page
- CheckyesterdayChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded the disease term 'Squamous cell carcinoma of the head and neck' and introduced a Genetic and Rare Diseases Information Center resources section on the study page.SummaryDifference0.2%

- Check30 days agoChange DetectedRevision tag updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check37 days agoChange DetectedPage revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now displays Revision: v3.4.2. The previous funding-status notice and the older Revision: v3.4.1 text have been removed.SummaryDifference0.4%

- Check73 days agoChange DetectedA site-wide notice about funding and NIH operations is added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to OPTIM Study: Immunotherapy in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.